Literature DB >> 15240697

Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands.

Aura Muntasell1, Montserrat Carrascal, Iñaki Alvarez, Laurence Serradell, Peter van Veelen, Frank A W Verreck, Frits Koning, Joaquín Abian, Dolores Jaraquemada.   

Abstract

Class II MHC (MHC II) expression is restricted to professional APCs and thymic epithelium but it also occurs in the epithelial cells of autoimmune organs which are the unique targets of the CD4 autoreactive T cells in endocrine autoimmune diseases. This specificity is presumably conditioned by an epithelium-specific peptide repertoire associated to MHC II at the cell surface. MHC II expression and function is dependent on the action of two main chaperones, invariant chain (Ii) and DM, whose expression is coregulated with MHC II. However, there is limited information about the in vivo expression levels of these molecules and uncoordinated expression has been demonstrated in class II-positive epithelial cells that may influence the MHC-associated peptide repertoires and the outcome of the autoimmune response. We have examined the pool of peptides associated to DR4 molecules expressed by a neuroendocrine epithelial cell and the consequences of Ii and DM coexpression. The RINm5F rat insulinoma cell line was transfected with HLA-DRB1*0401, Ii, and DM molecules in four different combinations: RIN-DR4, -DR4Ii, -DR4DM, and -DR4IiDM. The analysis of the peptide repertoire and the identification of the DR4 naturally processed ligands in each transfected cell were achieved by mass spectrometry. The results demonstrate that 1) the expression of Ii and DM affected the DR4 peptide repertoires by producing important variations in their content and in the origin of peptides; 2) these restrictions affected the stability and sequence of the peptides of each repertoire; and 3) Ii and DM had both independent and coordinate effects on these repertoires.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240697     DOI: 10.4049/jimmunol.173.2.1085

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.

Authors:  Dorothee Schmid; Marc Pypaert; Christian Münz
Journal:  Immunity       Date:  2006-12-21       Impact factor: 31.745

2.  Suppression of major histocompatibility complex class II-associated invariant chain enhances the potency of an HIV gp120 DNA vaccine.

Authors:  Xueqing Lu; Shuzhen Wu; Catherine E Blackwell; Robert E Humphreys; Eric von Hofe; Minzhen Xu
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

3.  MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells.

Authors:  Minu K Srivastava; Jacobus J Bosch; Ashley L Wilson; Martin J Edelman; Suzanne Ostrand-Rosenberg
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

4.  Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis.

Authors:  Martijn J C van Herwijnen; Lotte Wieten; Ruurd van der Zee; Peter J van Kooten; Josée P Wagenaar-Hilbers; Aad Hoek; Ineke den Braber; Stephen M Anderton; Mahavir Singh; Hugo D Meiring; Cécile A C M van Els; Willem van Eden; Femke Broere
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

5.  Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.

Authors:  Louis-Philippe Leroux; Manami Nishi; Sandy El-Hage; Barbara A Fox; David J Bzik; Florence S Dzierszinski
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

6.  T cell recognition of naturally presented epitopes of self-heat shock protein 70.

Authors:  Huib de Jong; Eva C Koffeman; Jennifer M Meerding; Rianne C Scholman; Lotte Wieten; Wilco de Jager; Mark Klein; Henny Otten; Femke van Wijk; Ruurd van der Zee; Johannes W J Bijlsma; Femke Broere; Willem van Eden; Berent J Prakken
Journal:  Cell Stress Chaperones       Date:  2014-01-15       Impact factor: 3.667

7.  The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes.

Authors:  James A Thompson; Minu K Srivastava; Jacobus J Bosch; Virginia K Clements; Bruce R Ksander; Suzanne Ostrand-Rosenberg
Journal:  Cancer Immunol Immunother       Date:  2007-08-28       Impact factor: 6.968

8.  Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells.

Authors:  Minu K Srivastava; Jacobus J Bosch; James A Thompson; Bruce R Ksander; Martin J Edelman; Suzanne Ostrand-Rosenberg
Journal:  Cancer Immunol Immunother       Date:  2008-03-06       Impact factor: 6.968

9.  Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells.

Authors:  Jacobus J Bosch; Uzoma K Iheagwara; Sarah Reid; Minu K Srivastava; Julie Wolf; Michal Lotem; Bruce R Ksander; Suzanne Ostrand-Rosenberg
Journal:  Cancer Immunol Immunother       Date:  2009-06-26       Impact factor: 6.968

10.  In Vivo Induction of Functionally Suppressive Induced Regulatory T Cells from CD4+CD25- T Cells Using an Hsp70 Peptide.

Authors:  Martijn J C van Herwijnen; Ruurd van der Zee; Willem van Eden; Femke Broere
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.